Industry Research Reports

Home > Reports > Service & Software > Global Molecular Docking and Virtual Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032

Global Molecular Docking and Virtual Screening Software Market Outlook, In‑Depth Analysis & Forecast to 2032

Industry: Service & Software

Published Date: 2026-07-16

Pages: 142 Pages

Report ld: 6977010

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Molecular Docking and Virtual Screening Software Market Size(US$)

CAGR 2026-2032

14.8%

Market Size,2032

USD 1,637

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 715 million

Market Forecast in 2032(Value)

US$ 1,637 million

CAGR

14.8%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Molecular Docking and Virtual Screening Software market is projected to grow from US$ 620 million in 2025 to US$ 1637 million by 2032, at a CAGR of 14.8% (2026-2032), driven by critical product segments and diverse end‑use applications.

Molecular docking and virtual screening software refers to computer-aided drug design tools used to predict interactions among small molecules, fragments, peptides, or protein complexes. It typically supports receptor preparation, ligand conformation generation, binding-site setup, conformational sampling, scoring, ranking, and visualization to screen large compound libraries for potential hits, with optional capabilities such as pharmacophore screening, shape similarity, induced-fit docking, covalent docking, and MM/GBSA or FEP rescoring. Deployment formats include desktop software, server or HPC clusters, cloud SaaS platforms, and API toolkits, mainly serving new drug discovery, drug repurposing, and lead optimization. The blended gross margin is approximately 75%.

Demand is mainly driven by early-stage innovative drug discovery, AI-enabled drug design platforms, computational chemistry services at CROs, drug repurposing, and academic research. As more protein structures become available, commercial compound libraries expand, and R&D teams seek higher pre-experimental screening efficiency, molecular docking and virtual screening software is moving from an expert-only tool to a standardized platform shared across project teams.

Product upgrades are centered on more complete workflows and higher computational efficiency. Established vendors maintain barriers through physics-based scoring functions, graphical modeling environments, and validated pharmaceutical use cases, while newer entrants emphasize GPU acceleration, cloud elasticity, AI-based pose prediction, automated data pipelines, and API integration. Buyers increasingly evaluate not only docking accuracy, but also protein and ligand preparation, batch job management, rescoring, traceable reporting, data security, and connectivity with ELN, LIMS, ADMET, and FEP platforms.

Regional demand remains concentrated among large pharmaceutical companies, biotech firms, and specialist CROs in North America and Europe, while China, India, and Singapore are growing faster due to the expansion of local AI drug discovery and CXO capabilities. Key risks include wet-lab validation conversion, pricing pressure from open-source tools, customer data security, cloud computing cost, and model generalization; opportunities lie in enterprise private deployment, ultra-large-scale screening, fragment and covalent drug design, DEL or automated synthesis integration, and target-family-specific solutions.

Report Includes:

This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Molecular Docking and Virtual Screening Software market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.

Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

Schrödinger
Dassault Systèmes
Chemical Computing Group
OpenEye Cadence Molecular Sciences
Cambridge Crystallographic Data Centre
Cresset
BioSolveIT
Molsoft
Molecular Discovery
DP Technology
XtalPi

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Structure-Based Docking Software
Ligand-Based Screening Software
Pharmacophore Screening Software
Shape and Electrostatic Similarity Software
AI-Assisted Docking Software

Segment by Application

Hit Discovery
Lead Optimization
Drug Repurposing
Fragment-Based Drug Design
Target Validation and Mechanism Study
Teaching and Academic Research

Segment by Category

Desktop Workstation Software
Server or HPC Software
Cloud SaaS Platform
API or Toolkit Software
Hybrid Deployment Software

Segment by Division

Small Molecule Docking Software
Fragment Docking Software
Peptide Docking Software
Covalent Ligand Docking Software
Protein-Protein Docking Software

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the Molecular Docking and Virtual Screening Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential

Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts

Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves

Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application

Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers

Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers

Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas

Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges

Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles

Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments

Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels

Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Introduction to Molecular Docking and Virtual Screening Software: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Molecular Docking and Virtual Screening Software Market Size by Type, 2021 vs 2025 vs 2032

1.2.2 Structure-Based Docking Software

1.2.3 Ligand-Based Screening Software

1.2.4 Pharmacophore Screening Software

1.2.5 Shape and Electrostatic Similarity Software

1.2.6 AI-Assisted Docking Software

1.3 Market Segmentation by Deployment Mode

1.3.1 Global Molecular Docking and Virtual Screening Software Market Size by Deployment Mode, 2021 vs 2025 vs 2032

1.3.2 Desktop Workstation Software

1.3.3 Server or HPC Software

1.3.4 Cloud SaaS Platform

1.3.5 API or Toolkit Software

1.3.6 Hybrid Deployment Software

1.4 Market Segmentation by Supported Molecule Type

1.4.1 Global Molecular Docking and Virtual Screening Software Market Size by Supported Molecule Type, 2021 vs 2025 vs 2032

1.4.2 Small Molecule Docking Software

1.4.3 Fragment Docking Software

1.4.4 Peptide Docking Software

1.4.5 Covalent Ligand Docking Software

1.4.6 Protein-Protein Docking Software

1.5 Market Segmentation by License Model

1.5.1 Global Molecular Docking and Virtual Screening Software Market Size by License Model, 2021 vs 2025 vs 2032

1.5.2 Perpetual License Software

1.5.3 Subscription License Software

1.5.4 Cloud Usage-Based Software

1.5.5 Academic or Free Software

1.5.6 Enterprise Site License Software

1.6 Market Segmentation by Application

1.6.1 Global Molecular Docking and Virtual Screening Software Market Size by Application, 2021 vs 2025 vs 2032

1.6.2 Hit Discovery

1.6.3 Lead Optimization

1.6.4 Drug Repurposing

1.6.5 Fragment-Based Drug Design

1.6.6 Target Validation and Mechanism Study

1.6.7 Teaching and Academic Research

1.7 Assumptions and Limitations

1.8 Study Objectives

1.9 Years Considered

2 Executive Summary

2.1 Global Molecular Docking and Virtual Screening Software Revenue Estimates and Forecasts (2021-2032)

2.2 Global Molecular Docking and Virtual Screening Software Revenue by Region

2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032

2.2.2 Historical and Forecasted Revenue by Region (2021-2032)

2.2.3 Global Revenue-Based Market Share by Region (2021-2032)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competitive Landscape

3.1 Global Molecular Docking and Virtual Screening Software Players’ Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2021-2026)

3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Players (2021 vs 2025)

3.2 Global Molecular Docking and Virtual Screening Software Companies Headquarters and Service Footprint

3.3 Key Player Market Share by Product Type

3.3.1 Structure-Based Docking Software: Market Share by Key Players

3.3.2 Ligand-Based Screening Software: Market Share by Key Players

3.3.3 Pharmacophore Screening Software: Market Share by Key Players

3.3.4 Shape and Electrostatic Similarity Software: Market Share by Key Players

3.3.5 AI-Assisted Docking Software: Market Share by Key Players

3.4 Global Molecular Docking and Virtual Screening Software Market Concentration and Dynamics

3.4.1 Global Market Concentration

3.4.2 Market Entry and Exit Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Product Segmentation

4.1 Global Molecular Docking and Virtual Screening Software Market by Type

4.1.1 Global Revenue by Type (2021-2032)

4.1.2 Global Revenue-Based Market Share by Type (2021-2032)

4.2 Global Molecular Docking and Virtual Screening Software Market by Deployment Mode

4.2.1 Global Revenue by Deployment Mode (2021-2032)

4.2.2 Global Revenue-Based Market Share by Deployment Mode (2021-2032)

4.3 Global Molecular Docking and Virtual Screening Software Market by Supported Molecule Type

4.3.1 Global Revenue by Supported Molecule Type (2021-2032)

4.3.2 Global Revenue-Based Market Share by Supported Molecule Type (2021-2032)

4.4 Global Molecular Docking and Virtual Screening Software Market by License Model

4.4.1 Global Revenue by License Model (2021-2032)

4.4.2 Global Revenue-Based Market Share by License Model (2021-2032)

4.5 Key Product Attributes and Differentiation

4.6 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.6.1 High-Growth Niches and Adoption Drivers

4.6.2 Profitability Hotspots and Cost Drivers

4.6.3 Substitution Threats

5 Downstream Applications and Customers

5.1 Global Molecular Docking and Virtual Screening Software Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)

5.1.2 Revenue-Based Market Share by Application (2021-2032)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2021-2032)

6.2 North America Key Players’ Revenue in 2025

6.3 North America Molecular Docking and Virtual Screening Software Market Size by Application (2021-2032)

6.4 North America Growth Accelerators and Market Barriers

6.5 North America Molecular Docking and Virtual Screening Software Market Size by Country

6.5.1 North America Revenue Trends by Country

6.5.2 US

6.5.3 Canada

6.5.4 Mexico

7 Europe

7.1 Europe Market Size (2021-2032)

7.2 Europe Key Players’ Revenue in 2025

7.3 Europe Molecular Docking and Virtual Screening Software Market Size by Application (2021-2032)

7.4 Europe Growth Accelerators and Market Barriers

7.5 Europe Molecular Docking and Virtual Screening Software Market Size by Country

7.5.1 Europe Revenue Trends by Country

7.5.2 Germany

7.5.3 France

7.5.4 U.K.

7.5.5 Italy

7.5.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2021-2032)

8.2 Asia-Pacific Key Players’ Revenue in 2025

8.3 Asia-Pacific Molecular Docking and Virtual Screening Software Market Size by Application (2021-2032)

8.4 Asia-Pacific Growth Accelerators and Market Barriers

8.5 Asia-Pacific Molecular Docking and Virtual Screening Software Market Size by Region

8.5.1 Asia-Pacific Revenue Trends by Region

8.6 China

8.7 Japan

8.8 South Korea

8.9 Australia

8.10 India

8.11 Southeast Asia

8.11.1 Indonesia

8.11.2 Vietnam

8.11.3 Malaysia

8.11.4 Philippines

8.11.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2021-2032)

9.2 Central and South America Key Players’ Revenue in 2025

9.3 Central and South America Molecular Docking and Virtual Screening Software Market Size by Application (2021-2032)

9.4 Central and South America Investment Opportunities and Key Challenges

9.5 Central and South America Molecular Docking and Virtual Screening Software Market Size by Country

9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)

9.5.2 Brazil

9.5.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2021-2032)

10.2 Middle East and Africa Key Players’ Revenue in 2025

10.3 Middle East and Africa Molecular Docking and Virtual Screening Software Market Size by Application (2021-2032)

10.4 Middle East and Africa Investment Opportunities and Key Challenges

10.5 Middle East and Africa Molecular Docking and Virtual Screening Software Market Size by Country

10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)

10.5.2 GCC Countries

10.5.3 Israel

10.5.4 Egypt

10.5.5 South Africa

11 Corporate Profile

11.1 Schrödinger

11.1.1 Schrödinger Corporation Information

11.1.2 Schrödinger Business Overview

11.1.3 Schrödinger Molecular Docking and Virtual Screening Software Product Features and Attributes

11.1.4 Schrödinger Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.1.5 Schrödinger Molecular Docking and Virtual Screening Software Revenue by Product in 2025

11.1.6 Schrödinger Molecular Docking and Virtual Screening Software Revenue by Application in 2025

11.1.7 Schrödinger Molecular Docking and Virtual Screening Software Revenue by Geographic Area in 2025

11.1.8 Schrödinger Molecular Docking and Virtual Screening Software SWOT Analysis

11.1.9 Schrödinger Recent Developments

11.2 Dassault Systèmes

11.2.1 Dassault Systèmes Corporation Information

11.2.2 Dassault Systèmes Business Overview

11.2.3 Dassault Systèmes Molecular Docking and Virtual Screening Software Product Features and Attributes

11.2.4 Dassault Systèmes Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.2.5 Dassault Systèmes Molecular Docking and Virtual Screening Software Revenue by Product in 2025

11.2.6 Dassault Systèmes Molecular Docking and Virtual Screening Software Revenue by Application in 2025

11.2.7 Dassault Systèmes Molecular Docking and Virtual Screening Software Revenue by Geographic Area in 2025

11.2.8 Dassault Systèmes Molecular Docking and Virtual Screening Software SWOT Analysis

11.2.9 Dassault Systèmes Recent Developments

11.3 Chemical Computing Group

11.3.1 Chemical Computing Group Corporation Information

11.3.2 Chemical Computing Group Business Overview

11.3.3 Chemical Computing Group Molecular Docking and Virtual Screening Software Product Features and Attributes

11.3.4 Chemical Computing Group Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.3.5 Chemical Computing Group Molecular Docking and Virtual Screening Software Revenue by Product in 2025

11.3.6 Chemical Computing Group Molecular Docking and Virtual Screening Software Revenue by Application in 2025

11.3.7 Chemical Computing Group Molecular Docking and Virtual Screening Software Revenue by Geographic Area in 2025

11.3.8 Chemical Computing Group Molecular Docking and Virtual Screening Software SWOT Analysis

11.3.9 Chemical Computing Group Recent Developments

11.4 OpenEye Cadence Molecular Sciences

11.4.1 OpenEye Cadence Molecular Sciences Corporation Information

11.4.2 OpenEye Cadence Molecular Sciences Business Overview

11.4.3 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Product Features and Attributes

11.4.4 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.4.5 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Revenue by Product in 2025

11.4.6 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Revenue by Application in 2025

11.4.7 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software Revenue by Geographic Area in 2025

11.4.8 OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software SWOT Analysis

11.4.9 OpenEye Cadence Molecular Sciences Recent Developments

11.5 Cambridge Crystallographic Data Centre

11.5.1 Cambridge Crystallographic Data Centre Corporation Information

11.5.2 Cambridge Crystallographic Data Centre Business Overview

11.5.3 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Product Features and Attributes

11.5.4 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.5.5 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Revenue by Product in 2025

11.5.6 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Revenue by Application in 2025

11.5.7 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software Revenue by Geographic Area in 2025

11.5.8 Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software SWOT Analysis

11.5.9 Cambridge Crystallographic Data Centre Recent Developments

11.6 Cresset

11.6.1 Cresset Corporation Information

11.6.2 Cresset Business Overview

11.6.3 Cresset Molecular Docking and Virtual Screening Software Product Features and Attributes

11.6.4 Cresset Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.6.5 Cresset Recent Developments

11.7 BioSolveIT

11.7.1 BioSolveIT Corporation Information

11.7.2 BioSolveIT Business Overview

11.7.3 BioSolveIT Molecular Docking and Virtual Screening Software Product Features and Attributes

11.7.4 BioSolveIT Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.7.5 BioSolveIT Recent Developments

11.8 Molsoft

11.8.1 Molsoft Corporation Information

11.8.2 Molsoft Business Overview

11.8.3 Molsoft Molecular Docking and Virtual Screening Software Product Features and Attributes

11.8.4 Molsoft Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.8.5 Molsoft Recent Developments

11.9 Molecular Discovery

11.9.1 Molecular Discovery Corporation Information

11.9.2 Molecular Discovery Business Overview

11.9.3 Molecular Discovery Molecular Docking and Virtual Screening Software Product Features and Attributes

11.9.4 Molecular Discovery Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.9.5 Molecular Discovery Recent Developments

11.10 DP Technology

11.10.1 DP Technology Corporation Information

11.10.2 DP Technology Business Overview

11.10.3 DP Technology Molecular Docking and Virtual Screening Software Product Features and Attributes

11.10.4 DP Technology Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.10.5 Company Ten Recent Developments

11.11 XtalPi

11.11.1 XtalPi Corporation Information

11.11.2 XtalPi Business Overview

11.11.3 XtalPi Molecular Docking and Virtual Screening Software Product Features and Attributes

11.11.4 XtalPi Molecular Docking and Virtual Screening Software Revenue and Gross Margin (2021-2026)

11.11.5 XtalPi Recent Developments

12 Molecular Docking and Virtual Screening Software Value Chain and Ecosystem Analysis

12.1 Molecular Docking and Virtual Screening Software Value Chain (Ecosystem Structure)

12.2 Upstream Analysis

12.2.1 Key Technologies, Platforms and Infrastructure

12.3 Midstream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Molecular Docking and Virtual Screening Software Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Molecular Docking and Virtual Screening Software Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

TABLE OF FIGURES

List of Tables

Table 1. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)

Table 2. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Deployment Mode, 2021 vs 2025 vs 2032 (US$ Million)

Table 3. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Supported Molecule Type, 2021 vs 2025 vs 2032 (US$ Million)

Table 4. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by License Model, 2021 vs 2025 vs 2032 (US$ Million)

Table 5. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)

Table 6. Global Molecular Docking and Virtual Screening Software Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 7. Global Molecular Docking and Virtual Screening Software Revenue by Region (US$ Million), 2021-2026

Table 8. Global Molecular Docking and Virtual Screening Software Revenue by Region (US$ Million), 2027-2032

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 10. Global Molecular Docking and Virtual Screening Software Revenue by Players (US$ Million), 2021-2026

Table 11. Global Molecular Docking and Virtual Screening Software Revenue-Based Market Share by Players (2021-2026)

Table 12. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)

Table 13. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Molecular Docking and Virtual Screening Software Revenue, 2025

Table 14. Global Molecular Docking and Virtual Screening Software Average Gross Margin (%) by Player (2021 vs 2025)

Table 15. Global Molecular Docking and Virtual Screening Software Companies Headquarters

Table 16. Global Molecular Docking and Virtual Screening Software Market Concentration Ratio (CR5)

Table 17. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis

Table 18. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 19. Global Molecular Docking and Virtual Screening Software Revenue by Type (US$ Million), 2021-2026

Table 20. Global Molecular Docking and Virtual Screening Software Revenue by Type (US$ Million), 2027-2032

Table 21. Global Molecular Docking and Virtual Screening Software Revenue by Deployment Mode (US$ Million), 2021-2026

Table 22. Global Molecular Docking and Virtual Screening Software Revenue by Deployment Mode (US$ Million), 2027-2032

Table 23. Global Molecular Docking and Virtual Screening Software Revenue by Supported Molecule Type (US$ Million), 2021-2026

Table 24. Global Molecular Docking and Virtual Screening Software Revenue by Supported Molecule Type (US$ Million), 2027-2032

Table 25. Global Molecular Docking and Virtual Screening Software Revenue by License Model (US$ Million), 2021-2026

Table 26. Global Molecular Docking and Virtual Screening Software Revenue by License Model (US$ Million), 2027-2032

Table 27. Key Product Attributes and Differentiation

Table 28. Global Molecular Docking and Virtual Screening Software Revenue by Application (US$ Million), 2021-2026

Table 29. Global Molecular Docking and Virtual Screening Software Revenue by Application (US$ Million), 2027-2032

Table 30. Molecular Docking and Virtual Screening Software High-Growth Sectors Demand CAGR (2026-2032)

Table 31. Top Customers by Region

Table 32. Top Customers by Application

Table 33. North America Molecular Docking and Virtual Screening Software Growth Accelerators and Market Barriers

Table 34. North America Molecular Docking and Virtual Screening Software Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 35. Europe Molecular Docking and Virtual Screening Software Growth Accelerators and Market Barriers

Table 36. Europe Molecular Docking and Virtual Screening Software Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 37. Asia-Pacific Molecular Docking and Virtual Screening Software Growth Accelerators and Market Barriers

Table 38. Asia-Pacific Molecular Docking and Virtual Screening Software Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 39. Central and South America Molecular Docking and Virtual Screening Software Investment Opportunities and Key Challenges

Table 40. Central and South America Molecular Docking and Virtual Screening Software Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 41. Middle East and Africa Molecular Docking and Virtual Screening Software Investment Opportunities and Key Challenges

Table 42. Middle East and Africa Molecular Docking and Virtual Screening Software Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)

Table 43. Schrödinger Corporation Information

Table 44. Schrödinger Description and Major Businesses

Table 45. Schrödinger Product Features and Attributes

Table 46. Schrödinger Revenue (US$ Million) and Gross Margin (2021-2026)

Table 47. Schrödinger Revenue Proportion by Product in 2025

Table 48. Schrödinger Revenue Proportion by Application in 2025

Table 49. Schrödinger Revenue Proportion by Geographic Area in 2025

Table 50. Schrödinger Molecular Docking and Virtual Screening Software SWOT Analysis

Table 51. Schrödinger Recent Developments

Table 52. Dassault Systèmes Corporation Information

Table 53. Dassault Systèmes Description and Major Businesses

Table 54. Dassault Systèmes Product Features and Attributes

Table 55. Dassault Systèmes Revenue (US$ Million) and Gross Margin (2021-2026)

Table 56. Dassault Systèmes Revenue Proportion by Product in 2025

Table 57. Dassault Systèmes Revenue Proportion by Application in 2025

Table 58. Dassault Systèmes Revenue Proportion by Geographic Area in 2025

Table 59. Dassault Systèmes Molecular Docking and Virtual Screening Software SWOT Analysis

Table 60. Dassault Systèmes Recent Developments

Table 61. Chemical Computing Group Corporation Information

Table 62. Chemical Computing Group Description and Major Businesses

Table 63. Chemical Computing Group Product Features and Attributes

Table 64. Chemical Computing Group Revenue (US$ Million) and Gross Margin (2021-2026)

Table 65. Chemical Computing Group Revenue Proportion by Product in 2025

Table 66. Chemical Computing Group Revenue Proportion by Application in 2025

Table 67. Chemical Computing Group Revenue Proportion by Geographic Area in 2025

Table 68. Chemical Computing Group Molecular Docking and Virtual Screening Software SWOT Analysis

Table 69. Chemical Computing Group Recent Developments

Table 70. OpenEye Cadence Molecular Sciences Corporation Information

Table 71. OpenEye Cadence Molecular Sciences Description and Major Businesses

Table 72. OpenEye Cadence Molecular Sciences Product Features and Attributes

Table 73. OpenEye Cadence Molecular Sciences Revenue (US$ Million) and Gross Margin (2021-2026)

Table 74. OpenEye Cadence Molecular Sciences Revenue Proportion by Product in 2025

Table 75. OpenEye Cadence Molecular Sciences Revenue Proportion by Application in 2025

Table 76. OpenEye Cadence Molecular Sciences Revenue Proportion by Geographic Area in 2025

Table 77. OpenEye Cadence Molecular Sciences Molecular Docking and Virtual Screening Software SWOT Analysis

Table 78. OpenEye Cadence Molecular Sciences Recent Developments

Table 79. Cambridge Crystallographic Data Centre Corporation Information

Table 80. Cambridge Crystallographic Data Centre Description and Major Businesses

Table 81. Cambridge Crystallographic Data Centre Product Features and Attributes

Table 82. Cambridge Crystallographic Data Centre Revenue (US$ Million) and Gross Margin (2021-2026)

Table 83. Cambridge Crystallographic Data Centre Revenue Proportion by Product in 2025

Table 84. Cambridge Crystallographic Data Centre Revenue Proportion by Application in 2025

Table 85. Cambridge Crystallographic Data Centre Revenue Proportion by Geographic Area in 2025

Table 86. Cambridge Crystallographic Data Centre Molecular Docking and Virtual Screening Software SWOT Analysis

Table 87. Cambridge Crystallographic Data Centre Recent Developments

Table 88. Cresset Corporation Information

Table 89. Cresset Description and Major Businesses

Table 90. Cresset Product Features and Attributes

Table 91. Cresset Revenue (US$ Million) and Gross Margin (2021-2026)

Table 92. Cresset Recent Developments

Table 93. BioSolveIT Corporation Information

Table 94. BioSolveIT Description and Major Businesses

Table 95. BioSolveIT Product Features and Attributes

Table 96. BioSolveIT Revenue (US$ Million) and Gross Margin (2021-2026)

Table 97. BioSolveIT Recent Developments

Table 98. Molsoft Corporation Information

Table 99. Molsoft Description and Major Businesses

Table 100. Molsoft Product Features and Attributes

Table 101. Molsoft Revenue (US$ Million) and Gross Margin (2021-2026)

Table 102. Molsoft Recent Developments

Table 103. Molecular Discovery Corporation Information

Table 104. Molecular Discovery Description and Major Businesses

Table 105. Molecular Discovery Product Features and Attributes

Table 106. Molecular Discovery Revenue (US$ Million) and Gross Margin (2021-2026)

Table 107. Molecular Discovery Recent Developments

Table 108. DP Technology Corporation Information

Table 109. DP Technology Description and Major Businesses

Table 110. DP Technology Product Features and Attributes

Table 111. DP Technology Revenue (US$ Million) and Gross Margin (2021-2026)

Table 112. DP Technology Recent Developments

Table 113. XtalPi Corporation Information

Table 114. XtalPi Description and Major Businesses

Table 115. XtalPi Product Features and Attributes

Table 116. XtalPi Revenue (US$ Million) and Gross Margin (2021-2026)

Table 117. XtalPi Recent Developments

Table 118. Technologies, Platforms and Infrastructure

Table 119. Distributors List

Table 120. Market Trends and Market Evolution

Table 121. Market Drivers and Opportunities

Table 122. Market Challenges, Risks, and Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)

Figure 2. Structure-Based Docking Software Product Picture

Figure 3. Ligand-Based Screening Software Product Picture

Figure 4. Pharmacophore Screening Software Product Picture

Figure 5. Shape and Electrostatic Similarity Software Product Picture

Figure 6. AI-Assisted Docking Software Product Picture

Figure 7. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Deployment Mode, 2021 vs 2025 vs 2032 (US$ Million)

Figure 8. Desktop Workstation Software Product Picture

Figure 9. Server or HPC Software Product Picture

Figure 10. Cloud SaaS Platform Product Picture

Figure 11. API or Toolkit Software Product Picture

Figure 12. Hybrid Deployment Software Product Picture

Figure 13. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Supported Molecule Type, 2021 vs 2025 vs 2032 (US$ Million)

Figure 14. Small Molecule Docking Software Product Picture

Figure 15. Fragment Docking Software Product Picture

Figure 16. Peptide Docking Software Product Picture

Figure 17. Covalent Ligand Docking Software Product Picture

Figure 18. Protein-Protein Docking Software Product Picture

Figure 19. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by License Model, 2021 vs 2025 vs 2032 (US$ Million)

Figure 20. Perpetual License Software Product Picture

Figure 21. Subscription License Software Product Picture

Figure 22. Cloud Usage-Based Software Product Picture

Figure 23. Academic or Free Software Product Picture

Figure 24. Enterprise Site License Software Product Picture

Figure 25. Global Molecular Docking and Virtual Screening Software Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)

Figure 26. Hit Discovery

Figure 27. Lead Optimization

Figure 28. Drug Repurposing

Figure 29. Fragment-Based Drug Design

Figure 30. Target Validation and Mechanism Study

Figure 31. Teaching and Academic Research

Figure 32. Molecular Docking and Virtual Screening Software Report Years Considered

Figure 33. Global Molecular Docking and Virtual Screening Software Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 34. Global Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 35. Global Molecular Docking and Virtual Screening Software Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 36. Global Molecular Docking and Virtual Screening Software Revenue-Based Market Share by Region (2021-2032)

Figure 37. Global Molecular Docking and Virtual Screening Software Revenue-Based Market Share Ranking (2025)

Figure 38. Tier Distribution by Revenue Contribution (2021 vs 2025)

Figure 39. Structure-Based Docking Software Revenue-Based Market Share by Player in 2025

Figure 40. Ligand-Based Screening Software Revenue-Based Market Share by Player in 2025

Figure 41. Pharmacophore Screening Software Revenue-Based Market Share by Player in 2025

Figure 42. Shape and Electrostatic Similarity Software Revenue-Based Market Share by Player in 2025

Figure 43. AI-Assisted Docking Software Revenue-Based Market Share by Player in 2025

Figure 44. Global Molecular Docking and Virtual Screening Software Revenue-Based Market Share by Type (2021-2032)

Figure 45. Global Molecular Docking and Virtual Screening Software Revenue-Based Market Share by Deployment Mode (2021-2032)

Figure 46. Global Molecular Docking and Virtual Screening Software Revenue-Based Market Share by Supported Molecule Type (2021-2032)

Figure 47. Global Molecular Docking and Virtual Screening Software Revenue-Based Market Share by License Model (2021-2032)

Figure 48. Global Molecular Docking and Virtual Screening Software Revenue-Based Market Share by Application (2021-2032)

Figure 49. North America Molecular Docking and Virtual Screening Software Revenue YoY (US$ Million), 2021-2032

Figure 50. North America Top 5 Players Molecular Docking and Virtual Screening Software Revenue (US$ Million) in 2025

Figure 51. North America Molecular Docking and Virtual Screening Software Revenue (US$ Million) by Application (2021-2032)

Figure 52. US Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 53. Canada Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 54. Mexico Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 55. Europe Molecular Docking and Virtual Screening Software Revenue YoY (US$ Million), 2021-2032

Figure 56. Europe Top 5 Players Molecular Docking and Virtual Screening Software Revenue (US$ Million) in 2025

Figure 57. Europe Molecular Docking and Virtual Screening Software Revenue (US$ Million) by Application (2021-2032)

Figure 58. Germany Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 59. France Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 60. U.K. Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 61. Italy Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 62. Russia Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 63. Asia-Pacific Molecular Docking and Virtual Screening Software Revenue YoY (US$ Million), 2021-2032

Figure 64. Asia-Pacific Top 8 Players Molecular Docking and Virtual Screening Software Revenue (US$ Million) in 2025

Figure 65. Asia-Pacific Molecular Docking and Virtual Screening Software Revenue (US$ Million) by Application (2021-2032)

Figure 66. Indonesia Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 67. Japan Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 68. South Korea Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 69. Australia Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 70. India Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 71. Indonesia Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 72. Vietnam Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 73. Malaysia Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 74. Philippines Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 75. Singapore Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 76. Central and South America Molecular Docking and Virtual Screening Software Revenue YoY (US$ Million), 2021-2032

Figure 77. Central and South America Top 5 Players Molecular Docking and Virtual Screening Software Revenue (US$ Million) in 2025

Figure 78. Central and South America Molecular Docking and Virtual Screening Software Revenue (US$ Million) by Application (2021-2032)

Figure 79. Brazil Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 80. Argentina Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 81. Middle East and Africa Molecular Docking and Virtual Screening Software Revenue YoY (US$ Million), 2021-2032

Figure 82. Middle East and Africa Top 5 Players Molecular Docking and Virtual Screening Software Revenue (US$ Million) in 2025

Figure 83. Middle East and Africa Molecular Docking and Virtual Screening Software Revenue (US$ Million) by Application (2021-2032)

Figure 84. GCC Countries Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 85. Israel Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 86. Egypt Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 87. South Africa Molecular Docking and Virtual Screening Software Revenue (US$ Million), 2021-2032

Figure 88. Molecular Docking and Virtual Screening Software Value Chain Mapping

Figure 89. Channels of Distribution (Direct Vs Distribution)

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Molecular Docking and Virtual Screening Software in 2026? zhanKai

The global market size of Molecular Docking and Virtual Screening Software in 2026 was 715 Million USD.

Which companies rank high in the global Molecular Docking and Virtual Screening Software market? shouQi

What was the global market size of Molecular Docking and Virtual Screening Software in 2032? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Molecular Docking and Virtual Screening Software market size from 2026 to 2032? shouQi

Related Reports

Global Molecular Docking and Virtual Screening Software Market Research Report 2026
The global Molecular Docking and Virtual Screening Software market was valued at US$ 620 million in 2025 and is anticipated to reach US$ 1637 million by 2032, at a CAGR of 14.8% from 2026 to 2032.
Published Date: 2026-07-16
Pages: 115
USD 2900.00
(Single User License)
Global Molecular Docking and Virtual Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Molecular Docking and Virtual Screening Software market size was US$ 620 million in 2025 and is forecast to reach a readjusted size of US$ 1637 million by 2032 with a CAGR of 14.8% during the forecast period 2026-2032.
Published Date: 2026-07-16
Pages: 116
USD 4250.00
(Single User License)
Molecular Docking and Virtual Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Molecular Docking and Virtual Screening Software was estimated to be worth US$ 620 million in 2025 and is projected to reach US$ 1637 million, growing at a CAGR of 14.8% from 2026 to 2032.
Published Date: 2026-07-16
Pages: 115
USD 3950.00
(Single User License)

Global Molecular Docking and Virtual Screening Software Market Research Report 2026
The global Molecular Docking and Virtual Screening Software market was valued at US$ 620 million in 2025 and is anticipated to reach US$ 1637 million by 2032, at a CAGR of 14.8% from 2026 to 2032.
Published: 2026-07-16
Pages: 115
USD 2900.00 (Single User License)
Global Molecular Docking and Virtual Screening Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Molecular Docking and Virtual Screening Software market size was US$ 620 million in 2025 and is forecast to reach a readjusted size of US$ 1637 million by 2032 with a CAGR of 14.8% during the forecast period 2026-2032.
Published: 2026-07-16
Pages: 116
USD 4250.00 (Single User License)
Molecular Docking and Virtual Screening Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Molecular Docking and Virtual Screening Software was estimated to be worth US$ 620 million in 2025 and is projected to reach US$ 1637 million, growing at a CAGR of 14.8% from 2026 to 2032.
Published: 2026-07-16
Pages: 115
USD 3950.00 (Single User License)